The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma

Oral Oncology

Volumn 49, Issue 1, 2013, Pages 71-78

  Chan, Sheng Chieh ^a,b   Hsu, Cheng Lung ^b   Yen, Tzu Chen ^b   Ng, Shu Hang ^b   Liao, Chun Ta ^b   Wang, Hung Ming ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

18F FDG PET CT; Epstein Barr virus; Head and neck cancer; Metabolic tumour volume; Metastasis; Nasopharyngeal carcinoma; Prognosis; Standardised uptake value; Total lesion glycolysis

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FOLINATE CALCIUM; GEMCITABINE; MITOMYCIN; UFT; VIRUS DNA; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; EPSTEIN BARR VIRUS; FEMALE; GLYCOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK FACTOR; TUMOR VOLUME; VIRUS LOAD; ADJUVANT CHEMOTHERAPY; CARCINOMA; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLOW UP; FORECASTING; GENETICS; IMAGE PROCESSING; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; VIROLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DNA, VIRAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; FORECASTING; HERPESVIRUS 4, HUMAN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84871413555     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.07.016     Document Type: Article

References (44)

1. W.I. Wei, and J.S. Sham Nasopharyngeal carcinoma Lancet 365 2005 2041 2054 (Pubitemid 40812341)
2. D. Kwong, J. Sham, and D. Choy The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients Int J Radiat Oncol Biol Phys 30 1994 1029 1036 (Pubitemid 24362510)
3. F.B. Geara, G. Sanguineti, S.L. Tucker, A.S. Garden, K.K. Ang, and W.H. Morrison Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival Radiother Oncol 43 1997 53 61 (Pubitemid 27191979)
4. A. Fandi, M. Bachouchi, N. Azli, A. Taamma, H. Boussen, and P. Wibault Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type J Clin Oncol 18 2000 1324 1330 (Pubitemid 30159852)
5. P.M. Teo, W.H. Kwan, W.Y. Lee, S.F. Leung, and P.J. Johnson Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma Cancer 77 1996 2423 2431 (Pubitemid 26169137)
6. E.P. Hui, S.F. Leung, J.S. Au, B. Zee, S. Tung, and D. Chua Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group Cancer 101 2004 300 306 (Pubitemid 38890833)
7. A.S. Allal, P. Dulguerov, M. Allaoua, C.A. Haenggeli, A. El-Ghazi el, and W. Lehmann Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J Clin Oncol 20 2002 1398 1404 (Pubitemid 34177448)
8. A.S. Allal, D.O. Slosman, T. Kebdani, M. Allaoua, W. Lehmann, and P. Dulguerov Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose Int J Radiat Oncol Biol Phys 59 2004 1295 1300 (Pubitemid 38954050)
9. S.C. Chan, J.T. Chang, H.M. Wang, C.Y. Lin, S.H. Ng, and K.H. Fan Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value Oral Oncol 45 2009 52 58
10. C.T. Liao, J.T. Chang, H.M. Wang, S.H. Ng, C. Hsueh, and L.Y. Lee Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes Int J Radiat Oncol Biol Phys 73 2009 764 771
11. M.K. Chung, H.S. Jeong, S.G. Park, J.Y. Jang, Y.I. Son, and J.Y. Choi Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res 15 2009 5861 5868
12. Y.M. Seol, B.R. Kwon, M.K. Song, Y.J. Choi, H.J. Shin, and J.S. Chung Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy Acta Oncol 49 2010 201 208
13. S.C. Chan, J.T. Chang, C.Y. Lin, S.H. Ng, H.M. Wang, and C.T. Liao Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification Nucl Med Commun 32 2011 989 996
14. P. Xie, J.B. Yue, H.X. Zhao, X.D. Sun, L. Kong, and Z. Fu Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma J Cancer Res Clin Oncol 136 2010 883 889
15. X. An, F.H. Wang, P.R. Ding, L. Deng, W.Q. Jiang, and L. Zhang Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy Cancer 117 2011 3750 3757
16. J.C. Lin, W.Y. Wang, K.Y. Chen, Y.H. Wei, W.M. Liang, and J.S. Jan Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2461 2470 (Pubitemid 38736543)
17. W.Y. Wang, C.W. Twu, H.H. Chen, J.S. Jan, R.S. Jiang, and J.Y. Chao Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma Clin Cancer Res 16 2010 1016 1024
18. C.L. Hsu, K.P. Chang, C.Y. Lin, H.K. Chang, C.H. Wang, and T.L. Lin Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma Head Neck 2011 10.1002/hed.21890
19. S.M. Larson, Y. Erdi, T. Akhurst, M. Mazumdar, H.A. Macapinlac, and R.D. Finn Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis Clin Positron Imaging 2 1999 159 171
20. Y.M. Lo, L.Y. Chan, K.W. Lo, S.F. Leung, J. Zhang, and A.T. Chan Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191 (Pubitemid 29136244)
21. W. Halfpenny, S.F. Hain, L. Biassoni, M.N. Maisey, J.A. Sherman, and M. McGurk FDG-PET. A possible prognostic factor in head and neck cancer Br J Cancer 86 2002 512 516 (Pubitemid 34185084)
22. H. Inokuchi, T. Kodaira, H. Tachibana, T. Nakamura, N. Tomita, and R. Nakahara Clinical usefulness of [(18)F] fluoro-2-deoxy-d-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection Int J Radiat Oncol Biol Phys 79 2011 747 755
23. C.T. Liao, H.M. Wang, J.T. Chang, C.Y. Lin, S.H. Ng, and S.F. Huang Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma Int J Radiat Oncol Biol Phys 77 2010 421 429
24. S.G. Hilsenbeck, and G.M. Clark Practical p-value adjustment for optimally selected cutpoints Stat Med 15 1996 103 112 (Pubitemid 26016014)
25. A. Fandi, M. Altun, N. Azli, J.P. Armand, and E. Cvitkovic Nasopharyngeal cancer: epidemiology, staging, and treatment Semin Oncol 21 1994 382 397 (Pubitemid 24191598)
26. K.H. Yu, P.M. Teo, W.Y. Lee, S.F. Leung, P.H. Choi, and P.J. Johnson Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning Clin Oncol (R Coll Radiol) 6 1994 167 171 (Pubitemid 24188580)
27. E.P. Zhang, P.G. Lian, K.L. Cai, Y.F. Chen, M.D. Cai, and X.F. Zheng Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients Int J Radiat Oncol Biol Phys 16 1989 301 305
28. C.K. Toh, D. Heng, Y.K. Ong, S.S. Leong, J. Wee, and E.H. Tan Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma Br J Cancer 92 2005 1382 1387 (Pubitemid 40705003)
29. S.W. Lee, S.Y. Nam, K.C. Im, J.S. Kim, E.K. Choi, and S.D. Ahn Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d- glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 2008 211 216
30. S.C. Chan, S.H. Ng, J.T. Chang, C.Y. Lin, Y.C. Chen, and Y.C. Chang Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging Eur J Nucl Med Mol Imaging 33 2006 1032 1040 (Pubitemid 44218599)
31. S.C. Chan, T.C. Yen, S.H. Ng, C.Y. Lin, H.M. Wang, and C.T. Liao Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management J Nucl Med 47 2006 1447 1454
32. J.T. Chang, S.C. Chan, T.C. Yen, C.T. Liao, C.Y. Lin, and K.J. Lin Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography Int J Radiat Oncol Biol Phys 62 2005 501 507 (Pubitemid 40704468)
33. F.Y. Liu, J.T. Chang, H.M. Wang, C.T. Liao, C.J. Kang, and S.H. Ng [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging J Clin Oncol 24 2006 599 604 (Pubitemid 46630422)
34. S.H. Ng, S.C. Chan, T.C. Yen, J.T. Chang, C.T. Liao, and S.F. Ko Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up Eur J Nucl Med Mol Imaging 36 2009 12 22
35. S.H. Ng, S.C. Chan, T.C. Yen, J.T. Chang, C.T. Liao, and S.F. Ko Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT Eur Radiol 19 2009 2965 2976
36. S.H. Ng, J.T. Chang, S.C. Chan, S.F. Ko, H.M. Wang, and C.T. Liao Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET Eur J Nucl Med Mol Imaging 31 2004 1073 1080 (Pubitemid 39050173)
37. T.C. Yen, J.T. Chang, S.H. Ng, Y.C. Chang, S.C. Chan, and K.J. Lin The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx J Nucl Med 46 2005 405 410 (Pubitemid 43093147)
38. P. Xie, J.B. Yue, Z. Fu, R. Feng, and J.M. Yu Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma Ann Oncol 21 2010 1078 1082
39. T.H. La, E.J. Filion, B.B. Turnbull, J.N. Chu, P. Lee, and K. Nguyen Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2009 1335 1341
40. P.G. Morris, G.A. Ulaner, A. Eaton, M. Fazio, K. Jhaveri, and S. Patil Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer Cancer 2012 10.1002/cncr.27579
41. C.L. Chen, W.N. Wen, J.Y. Chen, M.M. Hsu, and H.C. Hsu Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization Intervirology 36 1993 91 98
42. R. Pathmanathan, U. Prasad, G. Chandrika, R. Sadler, K. Flynn, and N. Raab-Traub Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia Am J Pathol 146 1995 1355 1367
43. Y.M. Lo, L.Y. Chan, A.T. Chan, S.F. Leung, K.W. Lo, and J. Zhang Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma Cancer Res 59 1999 5452 5455 (Pubitemid 29526455)
44. B.B. Ma, A. King, Y.M. Lo, Y.Y. Yau, B. Zee, and E.P. Hui Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys. 66 2006 714 720 (Pubitemid 44444855)